Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Haffner

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Nature Communications|October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerPaloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Cancer Discovery|November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer PhenotypesNavonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Nature Communications|September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.
The Journal of Clinical Investigation|June 2, 2025
PROX1 is an early driver of lineage plasticity in prostate cancerZhi Duan, Mingchen Shi, Anbarasu Kumaraswamy, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Cancer Research|October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate CancerMartin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Nature Communications|October 2, 2021
Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancerPaloma Cejas, Yingtian Xie, Alba Font-Tello, et al.
Cancer Discovery|November 18, 2022
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer PhenotypesNavonil De Sarkar, Robert D Patton, Anna-Lisa Doebley, et al.
Nature Communications|September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.
The Journal of Clinical Investigation|June 2, 2025
PROX1 is an early driver of lineage plasticity in prostate cancerZhi Duan, Mingchen Shi, Anbarasu Kumaraswamy, et al.
The Journal of Clinical Investigation|June 10, 2025
Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancerMartine P Roudier, Roman Gulati, Erolcan Sayar, et al.
Cancer Research|October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate CancerMartin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Pageof 17